FSRH | COC – risks of different oestrogen and progesterone

22nd July 2016 by Louise Hudman

FSRH | COC – risks of different oestrogen and progesterone

This is a statement from the FSRH on a study recently published on risks with COC use. This study looks at how the different dose of oestrogen and how the different progesterone affect the risk of PE, CVA and MI. Bottom line – we should be advising women choosing the COC that a 20mcg ethinylestradiol/levonorgestrel pill may have lower thrombotic risks (though there is no such pill available in the UK at present).

The study showed that:

  • levonorgestrel containing pills have a lower risk of PE than desogestrel and gestodene containing pills.
  • 20mcg ethinylestradiol containing pills have a lower risk of PE, ischaemic CVA and MI than pills containing more oestrogen.

How significant is this?

The results are significant. However, the absolute levels of risk are low and the study didn’t look at the background risks in the population.


Join to view the rest of this content, as well as access all the benefits of joining NASGP.



Already a member? Login to view this content.


"LocumDeck does everything you want it to do in an instant and with audit trails.

I absolutely love the facility for receiving Locum's invoices and the facility for signing the Pension Forms electronically and they are then instantly sent with an audit trail! It is fabulous!

You are notified the moment a Locum GP adds availability which is just fantastic, I spend a lot of time just chasing agencies to see if they have availability, so to be notified the moment availability is advertised is a new concept and very welcome! I have no hesitation in recommending LocumDeck - it has already eased my workload!"

Sue, Practice Manager in Portsmouth

See the full list of features within our NASGP membership plans